AU2021342331A1 - Mepyramine for use in the topical treatment of neuropathic pain - Google Patents

Mepyramine for use in the topical treatment of neuropathic pain Download PDF

Info

Publication number
AU2021342331A1
AU2021342331A1 AU2021342331A AU2021342331A AU2021342331A1 AU 2021342331 A1 AU2021342331 A1 AU 2021342331A1 AU 2021342331 A AU2021342331 A AU 2021342331A AU 2021342331 A AU2021342331 A AU 2021342331A AU 2021342331 A1 AU2021342331 A1 AU 2021342331A1
Authority
AU
Australia
Prior art keywords
topical composition
neuropathy
mepyramine
neuropathic pain
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2021342331A
Other languages
English (en)
Inventor
Patrick Delmas
Céline GRECO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique
Assistance Publique - Hôpitaux de Paris
Original Assignee
Centre National de la Recherche Scientifique
Assistance Publique - Hôpitaux de Paris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique, Assistance Publique - Hôpitaux de Paris filed Critical Centre National de la Recherche Scientifique
Publication of AU2021342331A1 publication Critical patent/AU2021342331A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2021342331A 2020-09-11 2021-09-10 Mepyramine for use in the topical treatment of neuropathic pain Abandoned AU2021342331A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20306009.0 2020-09-11
EP20306009.0A EP3967308A1 (en) 2020-09-11 2020-09-11 Mepyramine for use in the topical treatment of neuropathic pain
PCT/EP2021/074906 WO2022053598A1 (en) 2020-09-11 2021-09-10 Mepyramine for use in the topical treatment of neuropathic pain

Publications (1)

Publication Number Publication Date
AU2021342331A1 true AU2021342331A1 (en) 2023-04-13

Family

ID=72615785

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021342331A Abandoned AU2021342331A1 (en) 2020-09-11 2021-09-10 Mepyramine for use in the topical treatment of neuropathic pain

Country Status (7)

Country Link
US (1) US20230321059A1 (cg-RX-API-DMAC7.html)
EP (2) EP3967308A1 (cg-RX-API-DMAC7.html)
JP (1) JP2023540355A (cg-RX-API-DMAC7.html)
KR (1) KR20230083272A (cg-RX-API-DMAC7.html)
AU (1) AU2021342331A1 (cg-RX-API-DMAC7.html)
CA (1) CA3191653A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022053598A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026119772A1 (fr) 2024-12-02 2026-06-11 Assistance Publique Hopitaux De Paris Nanoparticules de mepyramine et de squalene

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8521342D0 (en) * 1985-08-27 1985-10-02 Univ Glasgow Medicament
EP0351897A3 (en) * 1988-06-17 1990-03-21 The Procter & Gamble Company Skin penetration system for salts of amine-functional drugs
US9511016B2 (en) * 2007-06-12 2016-12-06 Epicentrx, Inc. Topical composition for treating pain

Also Published As

Publication number Publication date
US20230321059A1 (en) 2023-10-12
WO2022053598A1 (en) 2022-03-17
JP2023540355A (ja) 2023-09-22
EP3967308A1 (en) 2022-03-16
CA3191653A1 (en) 2022-03-17
KR20230083272A (ko) 2023-06-09
EP4210699A1 (en) 2023-07-19

Similar Documents

Publication Publication Date Title
DE602004007225T2 (de) Methode zur behandlung von erkrankungen der unteren harnwege
DE69737592T2 (de) Mittel gegen juckreiz
JP4970685B2 (ja) 眼痛の処置方法
EP3265087B1 (en) Method of treatment with tradipitant
JP2010537988A (ja) 紅斑を治療するための改良ブリモニジン組成物
KR20190004815A (ko) 안과 치료제
EP3551166B1 (en) Topical phenytoin for use in the treatment of peripheral neuropathic pain
EA012176B1 (ru) Новое применение пептидных соединений для лечения боли при болезненной диабетической нейропатии
JP2003533475A (ja) ニコチン性アセチルコリン受容体アゴニストによる、膣乾燥の治療方法
DE60315258T2 (de) Behandlung von nicht-schmerzhaften blasenstörungen mit modulatoren der alpha-2-delta-untereinheit des calciumkanals
US20020192241A1 (en) Methods of using kavalactone compositions
JP2024012412A (ja) 局所と局部の麻酔と鎮痛
KR20010021854A (ko) 말초 작용성 항소양성 아편제
US20230321059A1 (en) Mepyramine for use in the topical treatment of neuropathic pain
Dietrich et al. Effects of topical 2% dorzolamide hydrochloride alone and in combination with 0.5% timolol maleate on intraocular pressure in normal feline eyes
JP2001526217A (ja) 血管性頭痛に対する局所麻酔薬の新規な使用
KR20250004041A (ko) 삼차 신경통 치료 및 그와 관련된 통증 감소에 사용하기 위한 트리메프라진
US20080255238A1 (en) Composition containing a thiourea derivative for preventing or treating pruritic or irritant skin diseases
KR20000029647A (ko) 양극성장애의치료방법
JP2000515865A (ja) 過剰攻撃を処置する方法
US20040204443A1 (en) Method for inducing pain relief using imidazo[1,2-a]pyridine derivatives
WO2006087481A1 (fr) Utilisation du rimonabant pour la preparation de medicaments utiles dans la prevention et le traitement du diabete du type 2
HK40119620A (en) Formulation for soft anticholinergic analogs
HK40119619A (en) Formulation for soft anticholinergic analogs
HK40119997A (en) Formulation for soft anticholinergic analogs

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period